Physician profile
Anthony Wong
NPI 1598917379
$2,709.97
in general payments reported to CMS, 2019-2025
19 companies · $312 in 2025
The $312 reported for 2025 was more than what 89% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $416 · 2022: $680 · 2023: $711 · 2024: $590 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $448.76 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $379.81 | 2022-2025 | I-Stat |
| Bioxcel Therapeutics, INC. | $246.21 | 2023 | Igalmi |
| Astrazeneca Pharmaceuticals LP | $225.37 | 2022-2024 | Andexxa |
| Janssen Pharmaceuticals, INC | $206.75 | 2021-2022 | |
| Grifols USA, LLC | $202.75 | 2023-2025 | Hyperrab |
| Abbvie INC. | $201.07 | 2022-2023 | Dalvance |
| Grt US Holding, INC. | $154.23 | 2021-2022 | |
| Penumbra, INC. | $123.98 | 2024 | Indigo System |
| Amgen INC. | $77.13 | 2022 | |
| Biodelivery Sciences International, INC. | $76.42 | 2021 | |
| Redhill Biopharma INC. | $70.50 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.29 | 2021 | |
| Fisher & Paykel Healthcare INC | $58.97 | 2023 | Fisher & Paykel Healthcare |
| Kedrion Biopharma, INC. | $54.00 | 2025 | Kedrab, Koate, Rhogam Ultra-Filtered Plus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Boston Scientific Corporation | $31.49 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $29.55 | 2023 | Exparel, Zilretta |
| Baudax Bio INC. | $18.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.